- Report
- April 2025
- 73 Pages
Global
From €5317EUR$5,850USD£4,515GBP
- Report
- August 2024
- 135 Pages
Global
From €2726EUR$2,999USD£2,315GBP
- Report
- March 2025
- 224 Pages
Global
From €4045EUR$4,450USD£3,435GBP
- Conference
- October 2025
- 1 Day
Global
€791EUR$901USD£649GBP
€913EUR$1,040USD£749GBP
- Conference
- June 2025
- 1 Day
Global
€791EUR$901USD£649GBP
€913EUR$1,040USD£749GBP
- Conference
- October 2025
- 3 Days
Asia Pacific
€1949EUR$2,219USD£1,599GBP
€2315EUR$2,636USD£1,899GBP
- Conference
- October 2025
- 2 Days
Europe
€1583EUR$1,803USD£1,299GBP
€1827EUR$2,080USD£1,499GBP
- Conference
- June 2025
- 3 Days
Asia Pacific
€1949EUR$2,219USD£1,599GBP
€2315EUR$2,636USD£1,899GBP
- Conference
- June 2025
- 2 Days
Europe
€1583EUR$1,803USD£1,299GBP
€1827EUR$2,080USD£1,499GBP
- Report
- March 2024
- 78 Pages
Global
From €4499EUR$4,950USD£3,821GBP
- Report
- August 2022
- 30 Pages
Global
From €2954EUR$3,250USD£2,508GBP
- Report
- July 2022
- 71 Pages
Global
From €1818EUR$2,000USD£1,544GBP
- Conference
- June 2025
- 2 Days
China
€1583EUR$1,803USD£1,299GBP
€1827EUR$2,080USD£1,499GBP
- Training
- October 2021
- 1 Day
Latin America
From €1181EUR$1,299USD£1,003GBP
- Report
- February 2018
- 135 Pages
Global
From €4545EUR$5,000USD£3,859GBP
- Training
- 7 Hours
Global
- Training
- 4 Hours
Europe
- Training
- 90 Minutes
Europe
- Report
- December 2022
- 94 Pages
Global
From €1818EUR$2,000USD£1,544GBP
- Report
- October 2022
- 308 Pages
Global
From €2272EUR$2,500USD£1,930GBP

The Marketing Authorization market is a key component of the Drug Discovery process. It is the process of obtaining approval from regulatory authorities to market a drug or medical device. This process involves submitting a dossier of data to the relevant regulatory body, which is then reviewed to ensure the product meets safety and efficacy standards. The dossier includes pre-clinical and clinical data, manufacturing information, and other relevant information. The process also includes post-marketing surveillance to ensure the product continues to meet safety and efficacy standards.
Companies in the Marketing Authorization market include AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more